VIRX
Viracta Therapeutics, Inc. Common Stock
VIRX
VIRX
Delisted
VIRX was delisted on the 3rd of February, 2025.
96 hedge funds and large institutions have $317M invested in Viracta Therapeutics, Inc. Common Stock in 2014 Q1 according to their latest regulatory filings, with 32 funds opening new positions, 32 increasing their positions, 22 reducing their positions, and 8 closing their positions.
Holders
96
Holders Change
+23
Holders Change %
+31.51%
% of All Funds
2.77%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
32
Increased
32
Reduced
22
Closed
8
Calls
$9.11M
Puts
$3.94M
Net Calls
+$5.17M
Net Calls Change
+$3.45M
Top Buyers
| 1 |
1
Fidelity Investments
Boston,
Massachusetts
|
$56.3M |
| 2 |
2
Franklin Resources
San Mateo,
California
|
$12.3M |
| 3 |
PCM
3
Palisade Capital Management
Fort Lee,
New Jersey
|
$9.12M |
| 4 |
O
4
OrbiMed
New York
|
$7.93M |
| 5 |
HM
5
HealthCor Management
New York
|
$4.56M |
Top Sellers
| 1 |
BA
1
BlackRock Advisors
Wilmington,
Delaware
|
$2.26M |
| 2 |
CI
2
Cowen Inc
New York
|
$492K |
| 3 |
3
Millennium Management
New York
|
$1.77M |
| 4 |
DCM
4
Decade Capital Management
New York
|
$0 |
| 5 |
5
D.E. Shaw & Co
New York
|
$1.84M |
